Abigail R. Manning

Abigail R. Manning

Auto-generated profile, based on publicly available information

Abigail R. Manning

From the Penn Statistics in Imaging and Visualization Center (A.R.M., M.L.M., T.R.-F., Q.C., C.M.O., R.T.S.), Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2023 in Journal of Neuroimaging
Verified
Journal Article
Closed access
AMAbigail R. Manning
Abigail R. Manning
EBErin S. Beck
Erin S. Beck
MSMatthew K Schindler
Matthew K Schindler
GNGovind Nair
Govind Nair
KCKelly A. Clark
Kelly A. Clark
ASAndrew J. Solomon
Andrew J. Solomon

27 September 2024 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
AMA.R. Manning
A.R. Manning
VLV. Letchuman
V. Letchuman
MMM.L. Martin
M.L. Martin
EGE. Gombos
E. Gombos
TRT. Robert-Fitzgerald
T. Robert-Fitzgerald
TCthe NAIMS Cooperative
the NAIMS Cooperative
BACKGROUND AND PURPOSE: The central vein sign (CVS) is a proposed diagnostic imaging biomarker for multiple sclerosis (MS). The proportion of white matter lesions exhibiting the CVS (CVS+) is higher in patients with MS compared with its radiologic mimics. Evaluation for CVS+ lesions in prior studies has been performed by manual rating, an approach that is time-consuming and has variable interrater reliability. Accurate automated methods would facilitate efficient assessment for CVS. The objective of this study was to compare the performance of an automated CVS detection method with manual rating for the diagnosis of MS. MATERIALS AND METHODS: 3T MRI was acquired in 86 participants undergoing evaluation for MS in a 9-site multicenter study. Participants presented with either typical or atypical clinical syndromes for MS. An automated CVS detection method was employed and compared with manual rating, including total CVS+ proportion and a simplified counting method in which experts visually identified up to 6 CVS+ lesions by using FLAIR* contrast (a voxelwise product of T2 FLAIR and postcontrast T2*-EPI). RESULTS: Automated CVS processing was completed in 79 of 86 participants (91%), of whom 28 (35%) fulfilled the 2017 McDonald criteria at the time of imaging. The area under the receiver operating characteristic curve (AUC) for discrimination between participants with and without MS for the automated CVS approach was 0.78 (95% CI: [0.67,0.88]). This was not significantly different from simplified manual counting methods (select6*) (0.80 [0.69,0.91]) or manual assessment of total CVS+ proportion (0.89 [0.82,0.96]). In a sensitivity analysis excluding 11 participants whose MRI exhibited motion artifact, the AUC for the automated method was 0.81 [0.70,0.91], which was not statistically different from that for select6* (0.79 [0.68,0.92]) or manual assessment of total CVS+ proportion (0.89 [0.81,0.97]). CONCLUSIONS: Automated CVS assessment was comparable to manual CVS scoring for differentiating patients with MS from those with other diagnoses. Large, prospective, multicenter studies utilizing automated methods and enrolling the breadth of disorders referred for suspicion of MS are needed to determine optimal approaches for clinical implementation of an automated CVS detection method.

25 March 2022 in medRxiv
Verified
Preprint
Open access
PDF file
AMAbigail R Manning
Abigail R Manning
EBErin S. Beck
Erin S. Beck
MSMatthew K. Schindler
Matthew K. Schindler
GNGovind Nair
Govind Nair
PPPrasanna Parvathaneni
Prasanna Parvathaneni
ASAndrew J. Solomon
Andrew J. Solomon
Background: Cortical demyelinated lesions are prevalent in multiple sclerosis (MS) and associated with disability; their presence on MRI has recently been incorporated into MS diagnostic criteria. Presently, advanced and ultra-high-field MRI — not routinely available in clinical practice — are the most sensitive methods for detection of cortical lesions, and approaches utilizing MRI sequences obtainable in routine clinical practice remain an unmet need. Objective: To assess the sensitivity of the ratio of T 1 -weighted and T 2 -weighted (T 1 /T 2 ) signal intensity for focal cortical lesions in comparison to other established, sensitive, advanced and high-field imaging methods. Methods: 3-tesla (3T) and 7-tesla (7T) MRI collected from 10 adults with MS participating in a natural history study at the National Institutes of Health were included in the study. T 1 /T 2 images were calculated by dividing 3T T 1 w images by 3T T 2 w fluid-attenuated inversion recovery (FLAIR) images for each participant. Cortical lesions were identified using 7T T 2 *w and T 1 w images and corresponding voxels were assessed on registered 3T images. For each participant, ratios derived from the median signal intensity of nonlesional tissue in the cortical region of the lesion and the median lesional voxel intensity were computed. These values were compared across 3T imaging sequences, including the calculated T 1 /T 2 image, as well as T 1 w, T 2 w, and Inversion Recovery Susceptibility Weighted Imaging with Enhanced T 2 weighting (IR-SWIET) images. Results: 614 cortical lesions were identified on 7T images. 3T T 1 /T 2 images demonstrated a larger contrast between median nonlesional cortical signal intensity and median cortical lesion signal intensity (median ratio = 1.29, range 1.19 – 1.38) when compared to T 1 w (1.01, 0.97 – 1.10, p<0.002), T 2 w (1.17, 1.07 – 1.26, p<0.002), and IR-SWIET (1.21, 1.01 – 1.29, p<0.03). Conclusion: T 1 /T 2 images are sensitive to cortical lesions. Approaches incorporating T 1 /T 2 could improve the accessibility of cortical lesion detection in research settings and clinical practice.